DMD

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hasegawa, H.
Right arrow Articles by Hashimoto, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hasegawa, H.
Right arrow Articles by Hashimoto, T.

Vol. 30, Issue 12, 1436-1440, December 2002

Kinetics of Sequential Metabolism from D-Leucine to L-Leucine via alpha -Ketoisocaproic Acid in Rat

Hiroshi Hasegawa, Takehisa Matsukawa, Yoshihiko Shinohara, and Takao Hashimoto

Department of Pathophysiology, School of Pharmacy, Tokyo University of Pharmacy and Life Science, Tokyo, Japan

D-Leucine is considered to be converted into the L-enantiomer by two steps: oxidative deamination to form alpha -ketoisocaproic acid (KIC) and subsequent stereospecific reamination of KIC. We investigated the pharmacokinetics of leucine enantiomers and KIC in rats to evaluate how deamination of D-leucine, reamination of KIC, and decarboxylation of KIC were affected to the overall extent that converted D-leucine into the L-enantiomer. After intravenous administrations of D-[2H7]leucine, L-[2H7]leucine, or [2H7]KIC, their plasma concentrations together with endogenous L-leucine and KIC were determined by gas chromatography-mass spectrometry. The rapid appearances of [2H7]KIC and L-[2H7]leucine were observed after administration of D-[2H7]leucine, whereas no detectable amount of D-[2H7]leucine was found after administrations of [2H7]KIC or L-[2H7]leucine. The fraction of conversion from D-[2H7]leucine into [2H7]KIC (FDright-arrow KIC) was estimated by using the area under the curve (AUC) of [2H7]KIC on the D-[2H7]leucine administration [AUCKIC(←D)] and that of [2H7]KIC on the [2H7]KIC administration (AUCKIC) to yield 70.1%. The fraction of conversion from [2H7]KIC to L-[2H7]leucine (FKICright-arrow L) was 40.2%. The fraction of conversion from D-leucine to the L-enantiomer (FDright-arrow L) was considered to be the product of FDright-arrow KIC and FKICright-arrow L, indicating that 28.2% of D-[2H7]leucine was metabolized to L-[2H7]leucine via [2H7]KIC. These results suggested that the relatively low conversion of D-leucine into the L-enantiomer might depend on irreversible decarboxylation of KIC. Regardless of [2H7]KIC, FDright-arrow L was also calculated directly using AUCL(←D) and AUCL to yield 27.5%. There were no differences between the two FDright-arrow L values, suggesting that almost all of the formation of L-[2H7]leucine from D-[2H7]leucine occurred via [2H7]KIC as an intermediate.


Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J ANIM SCIHome page
M. Du, Q. W. Shen, M. J. Zhu, and S. P. Ford
Leucine stimulates mammalian target of rapamycin signaling in C2C12 myoblasts in part through inhibition of adenosine monophosphate-activated protein kinase
J Anim Sci, April 1, 2007; 85(4): 919 - 927.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
H. Hasegawa, Y. Shinohara, K. Akahane, and T. Hashimoto
Direct Detection and Evaluation of Conversion of D-Methionine into L-Methionine in Rats by Stable Isotope Methodology
J. Nutr., August 1, 2005; 135(8): 2001 - 2005.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. Hasegawa, T. Matsukawa, Y. Shinohara, R. Konno, and T. Hashimoto
Role of renal D-amino-acid oxidase in pharmacokinetics of D-leucine
Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E160 - E165.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.